EXANE DERIVATIVES - DBV TECHNOLOGIES S A ownership

DBV TECHNOLOGIES S A's ticker is DBVT and the CUSIP is 23306J101. A total of 40 filers reported holding DBV TECHNOLOGIES S A in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of DBV TECHNOLOGIES S A
ValueSharesWeighting
Q2 2022$258,000
+60.2%
1010.0%0.00%
Q1 2022$161,000
-0.6%
1010.0%0.00%
Q4 2021$162,000
-67.3%
1010.0%0.00%
Q3 2021$495,000
-6.4%
1010.0%0.00%
Q2 2021$529,000
-1.7%
1010.0%0.00%
Q1 2021$538,000
-89.7%
101
-95.0%
0.00%
-100.0%
Q4 2020$5,240,000
+262.4%
2,000
+139.2%
0.00%
Q3 2020$1,446,000
-97.5%
836
-93.6%
0.00%
-100.0%
Q2 2020$57,068,000
+12.0%
13,0000.0%0.02%
+7.1%
Q1 2020$50,958,00013,0000.01%
Other shareholders
DBV TECHNOLOGIES S A shareholders Q2 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 4,831,155$12,319,0002.82%
Nan Fung Group Holdings Ltd 370,950$946,0000.65%
Boxer Capital, LLC 2,134,598$5,443,0000.34%
Ikarian Capital, LLC 316,939$1,401,0000.26%
Baker Brothers Advisors 14,614,264$37,266,0000.21%
COWEN AND COMPANY, LLC 160,764$410,0000.04%
Tidal Investments LLC 51,584$132,0000.01%
Schonfeld Strategic Advisors LLC 183,867$469,0000.01%
ExodusPoint Capital Management, LP 138,122$352,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 32,861$84,0000.00%
View complete list of DBV TECHNOLOGIES S A shareholders